You-kuan Yin

发表

[Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].

Jun Ye, Yi-Yang Hu, Ping Liu, 2003, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.

Jun Ye, C. Liu, Yi-Yang Hu, 2005, World journal of gastroenterology.

Enterococcus faecium-Related Outbreak with Molecular Evidence of Transmission from Pigs to Humans

Yi-Wei Tang, You-kuan Yin, Haijing Li, 2002, Journal of Clinical Microbiology.

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients

H. Ren, Lai Wei, J. Hou, 2013, Hepatology International.

Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.

Mengji Lu, You-kuan Yin, X. Weng, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double‐blind trial

J. Niu, G. Harb, H. Ren, 2007, Hepatology.

Major Outbreak of Toxic Shock-Like Syndrome Caused by Streptococcus mitis

D. Haas, Yi-Wei Tang, You-kuan Yin, 2003, Journal of Clinical Microbiology.

[516] A RANDOMIZED TRIAL OF SWITCHING TO TELBIVUDINE VERSUS CONTINUED LAMIVUDINE IN ADULTS WITH CHRONIC HEPATITIS B: RESULTS OF THE PRIMARY ANALYSIS AT WEEK 24

G. Harb, E. Zuckerman, Lai Wei, 2007 .

Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapy

Mengji Lu, You-kuan Yin, R. Mao, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy

Mengji Lu, M. Roggendorf, You-kuan Yin, 2006, Journal of medical virology.

Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

E. Zuckerman, Lai Wei, R. Safadi, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.

M. Mizokami, Yasuhito Tanaka, Lai Wei, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Inhibition of hepatitis B virus expression and replication by RNA interference

You-kuan Yin, Yu-xian Huang, Yingda L. Xie, 2007 .

[497] TWO-YEAR RESULTS OF A PHASE III COMPARATIVE TRIAL OF TELBIVUDINE VS LAMIVUDINE IN CHINESE PATIENTS

J. Niu, L. Zhu, J. Jia, 2007 .